文献速递主动脉疾病颈动脉与弓上血管外周动脉疾病

胸外主动脉上旁路手术在胸主动脉腔内修复和动脉闭塞性疾病治疗中是安全的

Extra-Thoracic Supra-aortic Bypass Surgery Is Safe in Thoracic Endovascular Aortic Repair and Arterial Occlusive Disease Treatment.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2018-04-22

这项单中心回顾性研究纳入107例因胸主动脉或胸腹主动脉腔内修复(57%;61/107)或动脉闭塞性疾病(42.9%;46/107)而行主动脉上旁路手术的患者(平均年龄69.2岁,38.4%为女性),评估死亡、神经并发症和通畅率。院内死亡率为10.2%(11/107),均来自去分支组且与急诊手术相关(p < .0001)。作者结论认为胸外主动脉上旁路手术并发症率低、中期通畅率高,是安全可行的治疗选择。

要点

  • 107例主动脉上旁路手术中,去分支组急诊手术与院内死亡相关(p < .0001)。
  • 36个月时96例患者的一期和二期通畅率分别为95%(SE 2.6%)和98%(SE 1.8%)。
  • 早期神经并发症10例,包括Horner综合征和声带麻痹各2例短暂病例及6例膈神经失用。

核心结论

  • 胸外主动脉上旁路手术并发症率低、中期旁路通畅率高,作为去分支联合胸主动脉瘤腔内修复及动脉闭塞性疾病的治疗选择是安全可行的。

研究设计与样本

  • 单中心回顾性研究纳入107例患者(平均年龄69.2岁,38.4%为女性),于2006年1月至2015年1月间因胸主动脉或胸腹主动脉腔内修复(57%;61/107)或动脉闭塞性疾病治疗(42.9%;46/107)行主动脉上旁路手术(颈动脉-锁骨下动脉旁路、颈动脉-颈动脉旁路和颈动脉-颈动脉-锁骨下动脉旁路)。
  • 107例去分支患者中26例(14.2%)因急性B型夹层或有症状动脉瘤在急诊条件下手术。
  • 随访通过影像判读和电话访谈进行,持续至2017年3月(平均42.1个月,范围0-125个月)。

主要发现

  • 院内死亡率为10.2%(11/107),全部来自去分支组且与急诊手术相关(p < .0001)。
  • 观察到1例手术相关死亡,为去分支组患者术后72个月因旁路闭塞后致死性卒中死亡。
  • 早期神经并发症见于10例患者,包括2例短暂性Horner综合征和声带麻痹以及6例膈神经失用。
  • 3例狭窄和1例闭塞被成功治疗;3例动脉闭塞性疾病患者因移植物周围反应而更换移植物。
  • 96例患者36个月时一期和二期通畅率分别为95%(SE 2.6%)和98%(SE 1.8%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The safety and feasibility of supra-aortic debranching as part of endovascular aortic surgery or as a treatment option for arterial occlusive disease (AOD) remains controversial. The aim of this study was to assess the clinical outcome of this surgery. METHODS: This single centre, retrospective study included 107 patients (mean age 69.2 years, 38.4% women) who underwent supra-aortic bypass surgery (carotid-subclavian bypass, carotid-carotid bypass, and carotid-carotid-subclavian bypass) because of thoracic or thoraco-abdominal endovascular aortic repair (57%; 61/107) or as AOD treatment (42.9%; 46/107) between January 2006 and January 2015. Mortality, morbidity with a focus on neurological complications, and patency rate were assessed. Twenty-six of 107 (14.2%) of the debranching patients were treated under emergency conditions because of acute type B dissection or symptomatic aneurysm. Follow up, conducted by imaging interpretation and telephone interviews, continued till March 2017 (mean 42.1, 0-125, months). RESULTS: The in hospital mortality rate was 10.2% (11/107), all of these cases from the debranching group and related to emergency procedures (p < .0001). One procedure related death of a patient in the debranching group, who had a lethal stroke 72 months post-operatively following bypass occlusion was observed. Early neurological complications were recognised in 10 patients, including two transient cases of Horner syndrome and vocal cord paralysis as well as six cases of phrenic nerve apraxia. Three cases of stenosis and one case of occlusion were successfully treated. In three AOD patients, the graft had to be exchanged because of peri-graft reaction. Primary and secondary patency rates of 96 patients after 36 months were 95% (SE 2.6%) and 98% (SE 1.8%), respectively. CONCLUSIONS: Extra-thoracic supra-aortic bypass surgery involves low complication rates and high mid-term bypass patency rates. It is a safe and feasible treatment option in the form of debranching in combination with endovascular aortic aneurysm repair and in AOD.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Gombert A, van Issum L, Barbati ME, et al. Extra-Thoracic Supra-aortic Bypass Surgery Is Safe in Thoracic Endovascular Aortic Repair and Arterial Occlusive Disease Treatment. Eur J Vasc Endovasc Surg. 2018. PMID: 29685679. doi:10.1016/j.ejvs.2018.03.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。